(225)Ac/(89)Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4-Positive Triple-Negative Breast Cancer. Babeker H, Njotu FN, Pougoue Ketchemen J, Monzer A, et al. J Nucl Med 2025 Feb 20:jnumed.124.268387. doi: 10.2967/jnumed.124.268387.

Read + Share

Amedeo Smart

Independent Medical Education

Babeker H, Njotu FN, Pougoue Ketchemen J, Monzer A, et al. (225)Ac/(89)Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4-Positive Triple-Negative Breast Cancer. J Nucl Med 2025 Feb 20:jnumed.124.268387. doi: 10.2967/jnumed.124.268387.
PMID: 39978811